SCHEMBL8800348

SCHEMBL8800348

CCc1c(-c2ccccc2)nc2ccccc2c1C(=O)NC(CCO)c1ccccc1

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TACR3 P29371 20/20 0.81
TACR2 P21452 9/20 0.81
OPRM1 P35372 2/20 0.67
CYP1A2 P05177 2/20 0.66
CYP3A4 P08684 2/20 0.66
CYP2C9 P11712 2/20 0.66
CYP2C19 P33261 2/20 0.66
CYP2D6 P10635 1/20 0.66
TACR1 P25103 1/20 0.66
MEN1 O00255 1/20 0.66
ALDH1A1 P00352 1/20 0.66
TP53 P04637 1/20 0.66
TSHR P16473 1/20 0.66
NFKB1 P19838 1/20 0.66
MAPK1 P28482 1/20 0.66
BLM P54132 1/20 0.66
PMP22 Q01453 1/20 0.66
KMT2A Q03164 1/20 0.66
ATM Q13315 1/20 0.66
SMN1; SMN2 Q16637 1/20 0.66

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8800343 1.00 TACR3 (0.81) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL6447407 0.90 TACR3 (1.00) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL6448703 0.90 TACR3 (1.00) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL6449768 0.90 TACR3 (1.00) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL7342220 0.89 TACR3 (0.80) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL7340896 0.89 TACR3 (0.80) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL8199228 0.88 TACR3 (0.78) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL8199230 0.88 TACR3 (0.78) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL13995504 0.85 TACR3 (0.78) TACR3TACR2OPRM1CYP1A2CYP3A4
SCHEMBL13972077 0.82 TACR3 (0.74) TACR3TACR2OPRM1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0804419-A1 QUINOLINE DERIVATIVES AS TACHYKININ NK 3 RECEPTOR ANTAGONISTS SmithKline Beecham Farmaceutici S.p.A. (IT) 1997-11-05 EP disclosed